Press-release for stocks publishing date 2022 - 04

Prices are updated after-hours

publishing date : 2022 - 04 - 08 crawled time : 19:00

save search

Moleculin Announces Presentation of Positive Preclinical Annamycin Data at the AACR 2022 Annual Meeting
Published: 2022-04-08 (Crawled : 19:00) - biospace.com/
MBRX | $4.6 3.37% 7.4K

Health Technology

| 133.87% | O: 0.0% H: 4.84% C: -0.54%
preclinical presentation positive pre-clinical

Corbus Presents First Preclinical Data for CRB-601 at the American Association for Cancer Research (AACR) Annual Meeting
Published: 2022-04-08 (Crawled : 19:00) - biospace.com/
CRBP | $35.5 -5.94% -6.37% 220K

Health Technology

| 8313.83% | O: 1.8% H: 5.02% C: -6.93%
crb-601 research preclinical cancer pre-clinical

Theseus Pharmaceuticals Announces Preclinical Data Characterizing Next-Generation Epidermal Growth Factor Receptor (EGFR) Inhibitors at the 2022 American Association for Cancer Research (AACR) Annual Meeting
Published: 2022-04-08 (Crawled : 19:00) - biospace.com/
THRX | $4.06 0.49% 0

| -70.86% | O: -0.79% H: 1.91% C: -0.72%
research preclinical cancer growth pre-clinical

Phio Pharmaceuticals Presents Positive New Data on PH-894 Demonstrating Antitumor Efficacy in Model of PD-1 Refractory Disease at the AACR Annual Meeting 2022
Published: 2022-04-08 (Crawled : 19:00) - biospace.com/
PHIO | News | $0.672 -4.0% -4.17% 91K

Health Technology

| -26.11% | O: -2.94% H: 175.0% C: 167.05%
ph-894 disease positive ph94

Blueprint Medicines Announces BLU-945 Proof-of-Concept Data Supporting Initiation of Comprehensive Combination Development Strategy in EGFR-mutant Non-Small Cell Lung Cancer
Published: 2022-04-08 (Crawled : 19:00) - biospace.com/
BPMC | $92.31 0.02% 0.02% 560K

Health Technology

| 34.96% | O: 0.94% H: 3.74% C: 0.86%
AZN | News | $71.175 0.46% 0.46% 6.1M

Health Technology

| 0.27% | O: -0.55% H: 1.53% C: 0.74%
blu-945 cancer

ESSA Pharma Announces the Presentation of Preclinical Data for its First Generation of Androgen Receptor N-Terminal Domain Degraders
Published: 2022-04-08 (Crawled : 19:00) - biospace.com/
EPIX | $6.38 -0.31% -0.31% 41K

Health Technology

| -14.97% | O: 1.77% H: 2.67% C: -1.34%
pharma preclinical presentation pre-clinical

Arcellx Presents Pre-Clinical Data for ACLX-002, a Novel CD123-targeted Universal CAR-T Cell Therapy for Relapsed or Refractory Acute Myeloid Leukemia at the American Association for Cancer Research Annual Meeting
Published: 2022-04-08 (Crawled : 19:00) - biospace.com/
ACLX | $52.795 -3.02% -3.12% 300K

| 305.06% | O: -0.31% H: 1.15% C: -0.54%
aclx-002 research pre-clinical car-t leukemia therapy cancer preclinical acute myeloid leukemia

Oncolytics Biotech® Presents New Data Demonstrating Durable Clinical Benefit in Relapsed/Refractory Multiple Myeloma Patients at the AACR Annual Meeting
Published: 2022-04-08 (Crawled : 19:00) - biospace.com/
ONCY | $1.045 -3.24% -3.35% 180K

Health Technology

| -29.94% | O: -0.64% H: 7.69% C: -0.64%
biotech

AbCellera Presents Data on T Cell Engager Platform at AACR 2022
Published: 2022-04-08 (Crawled : 19:00) - biospace.com/
ABCL | $3.9 -1.76% -1.79% 1.6M

| -60.0% | O: -0.41% H: 0.0% C: -6.9%
platform

Cardiff Oncology Announces Updated Clinical and New Biomarker Data from Phase 2 Metastatic Castration-Resistant Prostate Cancer Trial at the AACR Annual Meeting
Published: 2022-04-08 (Crawled : 19:00) - biospace.com/
CRDF | $4.16 -0.24% -0.24% 340K

Health Services

| 76.37% | O: -0.84% H: 4.68% C: -1.7%
trial cancer biomarkers phase 2 prostate cancer

Omega Therapeutics Presents Preclinical Data on OTX-2002, First-in-Class Epigenomic Controller, as Potential Treatment for Hepatocellular Carcinoma at the AACR Annual Meeting 2022
Published: 2022-04-08 (Crawled : 19:00) - biospace.com/
OMGA | $2.335 -0.21% -0.21% 200K

| -62.36% | O: -1.13% H: 5.23% C: 1.31%
otx-2002 treatment preclinical therapeutics potential pre-clinical

Jazz Pharmaceuticals Presents Pre-Clinical Data for Pan-RAF Inhibitor JZP815, including Pharmacokinetic Properties and Efficacy in Multiple Solid Tumor Types
Published: 2022-04-08 (Crawled : 19:00) - biospace.com/
JAZZ | $108.38 -1.18% -1.19% 400K

Health Technology

| -35.78% | O: -0.42% H: 0.88% C: -1.34%
jzp815 pre-clinical preclinical

Syros Presents New Preclinical Data on its CDK12 Inhibitor Program at American Association for Cancer Research (AACR) Annual Meeting 2022
Published: 2022-04-08 (Crawled : 19:00) - biospace.com/
SYRS | $5.055 -1.65% -1.68% 90K

Health Technology

| 373.83% | O: 0.0% H: 10.28% C: 7.48%
cdk12 research preclinical program cancer pre-clinical

LivePerson upgrades Conversation Assist to supercharge agents with real-time AI recommendations
Published: 2022-04-08 (Crawled : 19:00) - prnewswire.com
FNCTF | News | $11.16 -20.84% 130

Communications

| Email alert Add to watchlist
LPSN S | $0.5034 1.68% 1.65% 2.3M

Technology Services

| Email alert Add to watchlist

Worldwide Microscopy Devices Industry to 2028 - by Product Type, Application, End-user and Region
Published: 2022-04-08 (Crawled : 19:00) - prnewswire.com
BRKR | $82.21 -0.3% -0.3% 980K

Health Technology

| Email alert Add to watchlist
NINOY | $10.27 -3.3% 150K

Manufacturing

| Email alert Add to watchlist
NINOF | $10.245 -14.1% 100

Consumer Durables

| Email alert Add to watchlist

Texas Instruments to webcast its 2022 annual meeting of stockholders
Published: 2022-04-08 (Crawled : 19:00) - prnewswire.com
TXN | $174.8 5.64% 5.33% 14M

Electronic Technology

| Email alert Add to watchlist